CU Medical Systems Statistics

Total Valuation

CU Medical Systems has a market cap or net worth of KRW 31.67 billion. The enterprise value is 60.62 billion.

Market Cap	31.67B
Enterprise Value	60.62B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

CU Medical Systems has 48.12 million shares outstanding. The number of shares has increased by 3.80% in one year.

Current Share Class	n/a
Shares Outstanding	48.12M
Shares Change (YoY)	+3.80%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	17.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.81
PB Ratio	0.57
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.57, with an EV/FCF ratio of -6.24.

EV / Earnings	-9.20
EV / Sales	1.54
EV / EBITDA	8.57
EV / EBIT	12.29
EV / FCF	-6.24

Financial Position

The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.67.

Current Ratio	2.75
Quick Ratio	2.04
Debt / Equity	0.67
Debt / EBITDA	5.30
Debt / FCF	-3.86
Interest Coverage	8.90

Financial Efficiency

Return on equity (ROE) is -11.05% and return on invested capital (ROIC) is 3.44%.

Return on Equity (ROE)	-11.05%
Return on Assets (ROA)	3.16%
Return on Capital (ROIC)	3.44%
Revenue Per Employee	338.98M
Profits Per Employee	-56.79M
Employee Count	116
Asset Turnover	0.40
Inventory Turnover	2.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.26%
50-Day Moving Average	745.26
200-Day Moving Average	752.28
Relative Strength Index (RSI)	25.24
Average Volume (20 Days)	135,558

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CU Medical Systems had revenue of KRW 39.32 billion and -6.59 billion in losses. Loss per share was -136.89.

Revenue	39.32B
Gross Profit	19.99B
Operating Income	4.93B
Pretax Income	-6.14B
Net Income	-6.59B
EBITDA	7.07B
EBIT	4.93B
Loss Per Share	-136.89

Full Income Statement

Balance Sheet

The company has 9.01 billion in cash and 37.46 billion in debt, giving a net cash position of -28.46 billion or -591.29 per share.

Cash & Cash Equivalents	9.01B
Total Debt	37.46B
Net Cash	-28.46B
Net Cash Per Share	-591.29
Equity (Book Value)	56.22B
Book Value Per Share	1,157.97
Working Capital	20.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.20 billion and capital expenditures -19.91 billion, giving a free cash flow of -9.71 billion.

Operating Cash Flow	10.20B
Capital Expenditures	-19.91B
Free Cash Flow	-9.71B
FCF Per Share	-201.83

Full Cash Flow Statement

Margins

Gross margin is 50.84%, with operating and profit margins of 12.55% and -16.75%.

Gross Margin	50.84%
Operating Margin	12.55%
Pretax Margin	-15.61%
Profit Margin	-16.75%
EBITDA Margin	17.98%
EBIT Margin	12.55%
FCF Margin	-24.70%

Dividends & Yields

CU Medical Systems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.80%
Shareholder Yield	-3.80%
Earnings Yield	-20.80%
FCF Yield	-30.67%

Stock Splits

The last stock split was on April 12, 2016. It was a forward split with a ratio of 2.

Last Split Date	Apr 12, 2016
Split Type	Forward
Split Ratio	2

Scores

CU Medical Systems has an Altman Z-Score of 0.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.95
Piotroski F-Score	n/a